Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Correlations between age and higher cognitive function in schizophrenia subgroups

William P Horan, Gerald Goldstein

    Schizophrenia Research
    |May 6, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction.

    Schizophrenia bulletin open·2026
    Same author

    Effects of Xanomeline and Trospium Chloride for Negative Symptoms Associated With Physical Activity in Younger and Older Adults with Schizophrenia: Results From a 52-Week, Open-label Clinical Trial.

    Schizophrenia research·2026
    Same author

    A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms.

    Schizophrenia bulletin open·2026
    Same author

    Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophrenia.

    Schizophrenia research·2026
    Same author

    Does Xanomeline/Trospium Have Unique Benefits for Cognitive Impairment Associated With Schizophrenia? Response to Tandon.

    The American journal of psychiatry·2025
    Same author

    A transdiagnostic approach to understanding neural responsivity to reward and its links to social motivation.

    Schizophrenia research. Cognition·2025
    Same journal

    Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.

    Schizophrenia research·2026
    Same journal

    Converting negative symptom dimension scores across SANS and PANSS.

    Schizophrenia research·2026
    Same journal

    Inflammation-associated alterations in mGluR transcript expression in the human nucleus accumbens independent of schizophrenia diagnosis.

    Schizophrenia research·2026
    Same journal

    One social interaction after another: Dynamic modeling of social experience in schizophrenia.

    Schizophrenia research·2026
    Same journal

    Reduced synaptic plasticity and E/I imbalance drive peripersonal space boundaries expansion in schizophrenia.

    Schizophrenia research·2026
    Same journal

    Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis.

    Schizophrenia research·2026
    See all related articles